Search for a report

Reports

  • You are here:
  • Home
  • Downloads
  • GLOBAL NEUROVASCULAR DEVICES / INTERVENTIONAL NEUROLOGY MARKET FORECAST 2021-2028

GLOBAL NEUROVASCULAR DEVICES / INTERVENTIONAL NEUROLOGY MARKET FORECAST 2021-2028

The global neurovascular devices / interventional neurology market is anticipated to register a CAGR of 5.08% between 2021 and 2028, and is expected to generate revenue of $4293.9 million by 2028. Neurovascular devices are used to treat disorders related to blood vessels that carry oxygen-rich blood to the brain. The dominant factor contributing to the growth of the neurovascular devices market is the surge in the geriatric population.

GLOBAL NEUROVASCULAR DEVICES / INTERVENTIONAL NEUROLOGY MARKET FORECAST 2021-2028

Global Neurovascular Devices / Interventional Neurology Market by Product (Embolization Devices, Accessory Devices, Revascularization Devices, Thrombectomy Devices, Embolic Protection Devices) Market by Application (Aneurysm, Ischemic Stroke, Stenosis, Arteriovenous Malformation (AVM), Other Applications) and by Geography

Request free sample

The global neurovascular devices / interventional neurology market is anticipated to register a CAGR of 5.08% between 2021 and 2028, and is expected to generate revenue of $4293.9 million by 2028. Neurovascular devices are used to treat disorders related to blood vessels that carry oxygen-rich blood to the brain. The dominant factor contributing to the growth of the neurovascular devices market is the surge in the geriatric population.
Neurovascular Devices Interventional Neurology Market

To learn more about this report, request a free sample copy

Key factors propelling the global neurovascular devices / interventional neurology market growth are:

  • Incidences of neurovascular conditions
    • Neurovascular conditions include hemorrhage stroke, vascular malformation, ischemic stroke, brain aneurysm, brain tumors, etc. In addition, lifestyle habits, genetic disorders, associated chronic diseases may cause the growth of neurovascular diseases.
  • Demand for minimally invasive procedures
  • Surging geriatric population
  • Prevalence of underlying disease conditions leading to neurovascular diseases

Major growth restraining factors:

  • Exorbitant cost of neurovascular devices
    • The neurovascular devices market growth is affected by the high cost of the embolization coils and related products. Since the coils are made from bare metal platinum and expensive alloys, the product’s manufacturing cost is higher.
  • Lack of adequate number of trained neurosurgeons

The report scope of the global neurovascular devices / interventional neurology market includes the segmentation analysis of product and application. One of these segments is further classified to provide a detailed analysis of the studied market.

Market by Application:

  • Aneurysm
    • Aneurysm is the dominating application in the neurovascular devices market.
    • An aneurysm is a medical condition, which is also termed as ballooning of blood vessels. This disease condition involves a weak area in a blood vessel that usually enlarges due to the constant blood flow pressure.
  • Ischemic Stroke
  • Stenosis
  • Arteriovenous Malformation (AVM)
    • Arteriovenous malformation is the fastest-growing application.
    • Arteriovenous malformation is an unusual condition in the vascular capillary system in which poorly developed blood vessels entangle to form a complicated mass with a higher bleeding rate.
  • Other Applications

Geographically, the global neurovascular devices / interventional neurology market has been segmented based on four major regions, which include:

  • North America: The United States and Canada
    • North America is set to be the dominating region in the global market by 2028.
    • In the United States, the incidences of neurovascular diseases are increasing significantly. It is among the leading cause of death across the country.
    • Similarly, hemorrhagic stroke and ischemic stroke incidences are on the rise. Such factors contribute to market growth.
  • Europe: The United Kingdom, Germany, Italy, France, Belgium, Russia, Poland, and Rest of Europe
  • Asia-Pacific: Japan, India, China, South Korea, Australia & New Zealand, Thailand, Indonesia, Vietnam, and Rest of Asia-Pacific
  • Rest of World: Latin America, the Middle East & Africa

The major players in the global neurovascular devices / interventional neurology market are:

  • B Braun Melsungen AG
  • Johnson & Johnson (Cerenovus)
  • Medtronic Inc
  • Microport Scientific Corporation
  • Stryker Corporation

Key strategies adopted by some of the neurovascular devices companies:

In April 2021, a partnership was formed with Surgical Theater by Medtronic to offer the first augmented reality platform for real-time during complex use during cranial procedures.

Key findings of the global neurovascular devices / interventional neurology market:

  • Technological advancements related to neurovascular devices aid market growth.
  • The thriving healthcare market offers growth opportunities.
  • The ongoing clinical trials for the treatment of stroke contribute to the overall market growth.

 

Frequently Asked Questions (FAQs):

  • How does the prevalence of aging people contribute to the global neurovascular devices / interventional neurology market growth?

A: Aging has been linked with various chronic diseases. Neurological diseases are most commonly observed in older adults, affecting between 5% and 55% of people aged 55 and above. In addition, neurological and mental disorders amongst older adults account for 6.6% of the total disability (DALYs) for this age group.

  • What is the role of hypertension and intracranial stenosis on demand for neurovascular diseases?

A: People suffering from hypertension and intracranial stenosis are at higher risk for ischemic stroke. Thus, it leads to demand for early treatment of these neurovascular diseases, which requires the use of neurovascular devices.

  • What is the impact of COVID-19 on the global neurovascular devices / interventional neurology market?

A: The surge of COVID-19 cases has resulted in the cancellation of doctor’s appointments, reduced demand for elective neurosurgery, disruption in the supply chain due to a long lockdown period, thereby affecting the market growth.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • KEY DRIVERS
      • INCIDENCE OF NEUROVASCULAR CONDITIONS
      • DEMAND FOR MINIMALLY INVASIVE PROCEDURES
      • SIGNIFICANCE OF NEUROLOGICAL DISEASES IN GERIATRIC POPULATION
      • PREVALENCE OF UNDERLYING DISEASE CONDITIONS
    • KEY RESTRAINTS
      • EXORBITANT COST OF NEUROVASCULAR DEVICES
      • LACK OF ADEQUATE NUMBER OF TRAINED NEUROSURGEONS
  1. KEY ANALYTICS
    • IMPACT OF COVID-19 ON NEUROVASCULAR DEVICES MARKET
    • KEY MARKET TRENDS
    •    PORTER’S FIVE FORCES ANALYSIS
      • BUYERS POWER
      • SUPPLIERS POWER
      • SUBSTITUTION
      • NEW ENTRY
      • INDUSTRY RIVALRY
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
  2. MARKET BY PRODUCT
    • EMBOLIZATION DEVICES
      • EMBOLIC COILS
        • COATED DETACHABLE COILS
        • BARE DETACHABLE COILS
      • COIL ASSIST STENT
      • CLIPPINGS
      • COIL ASSIST BALLOON
    • ACCESSORY DEVICES
      • MICROCATHETERS
      • MICRO GUIDEWIRES
    • REVASCULARIZATION DEVICES
      • CAROTID ARTERY STENTS
      • FLOW DIVERSION STENTS
    • THROMBECTOMY DEVICES
      • CLOT RETRIEVAL DEVICES
      • SUCTION AND ASPIRATION DEVICES
      • SNARES
    • EMBOLIC PROTECTION DEVICES
      • BALLOON OCCLUSION DEVICES
      • DISTAL FILTER DEVICES
  1. MARKET BY APPLICATION
    • ANEURYSM
    • ISCHEMIC STROKE
    • STENOSIS
    • ARTERIOVENOUS MALFORMATION (AVM)
    • OTHER APPLICATIONS
  2. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      •    COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    •  EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      •    COUNTRY ANALYSIS
        • GERMANY
        • UNITED KINGDOM
        • FRANCE
        • ITALY
        • RUSSIA
        • POLAND
        • BELGIUM
        • REST OF EUROPE
    •  ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      •    COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • AUSTRALIA & NEW ZEALAND
        • INDIA
        • SOUTH KOREA
        • THAILAND
        • INDONESIA
        • VIETNAM
        • REST OF ASIA-PACIFIC
    •  REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      •    REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • KEY STRATEGIC DEVELOPMENTS
      • MERGERS & ACQUISITIONS
      • PRODUCT LAUNCHES & DEVELOPMENTS
      • PARTNERSHIPS & AGREEMENTS
      • BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
    • COMPANY PROFILES
      • ACANDIS GMBH
      • ASAHI INTECC
      • BALT
      • B BRAUN MELSUNGEN AG
      • INTEGER HOLDINGS CORPORATION
      • JOHNSON & JOHNSON (CERENOVUS)
      • KANEKA CORPORATION
      • MEDTRONIC INC
      • MEMRY CORPORATION
      • MICROPORT SCIENTIFIC CORPORATION
      • PENUMBRA INC
      • PHENOX GMBH
      • RAPID MEDICAL
      • SENSOME
      • STRYKER CORPORATION
      • TERUMO MEDICAL CORPORATION (MICROVENTION INC)

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – NEUROVASCULAR DEVICES

TABLE 2: GLOBAL NEUROVASCULAR DEVICES MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: GLOBAL NEUROVASCULAR DEVICES MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 4: GLOBAL EMBOLIZATION DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: GLOBAL EMBOLIZATION DEVICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 6: GLOBAL EMBOLIZATION DEVICES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: GLOBAL EMBOLIZATION DEVICES MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 8: GLOBAL EMBOLIC COILS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: GLOBAL EMBOLIC COILS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 10: GLOBAL ACCESSORY DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 11: GLOBAL ACCESSORY DEVICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 12: GLOBAL ACCESSORY DEVICES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 13: GLOBAL ACCESSORY DEVICES MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 14: GLOBAL REVASCULARIZATION DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 15: GLOBAL REVASCULARIZATION DEVICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 16: GLOBAL REVASCULARIZATION DEVICES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 17: GLOBAL REVASCULARIZATION DEVICES MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 18: GLOBAL THROMBECTOMY DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 19: GLOBAL THROMBECTOMY DEVICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 20: GLOBAL THROMBECTOMY DEVICES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 21: GLOBAL THROMBECTOMY DEVICES MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 22: GLOBAL EMBOLIC PROTECTION DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 23: GLOBAL EMBOLIC PROTECTION DEVICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 24: GLOBAL EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 25: GLOBAL EMBOLIC PROTECTION DEVICES MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 26: GLOBAL NEUROVASCULAR DEVICES MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 27: GLOBAL NEUROVASCULAR DEVICES MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 28: GLOBAL ANEURYSM MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 29: GLOBAL ANEURYSM MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 30: GLOBAL ISCHEMIC STROKE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 31: GLOBAL ISCHEMIC STROKE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 32: GLOBAL STENOSIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 33: GLOBAL STENOSIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 34: GLOBAL ARTERIOVENOUS MALFORMATION (AVM) MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 35: GLOBAL ARTERIOVENOUS MALFORMATION (AVM) MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 36: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 37: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 38: GLOBAL NEUROVASCULAR DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 39: GLOBAL NEUROVASCULAR DEVICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 40: NORTH AMERICA NEUROVASCULAR DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 41: NORTH AMERICA NEUROVASCULAR DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 42: LEADING PLAYERS OPERATING IN THE NORTH AMERICA NEUROVASCULAR DEVICES MARKET

TABLE 43: EUROPE NEUROVASCULAR DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 44: EUROPE NEUROVASCULAR DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 45: LEADING PLAYERS OPERATING IN EUROPE NEUROVASCULAR DEVICES MARKET

TABLE 46: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 47: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 48: LEADING PLAYERS OPERATING IN ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET

TABLE 49: REST OF WORLD NEUROVASCULAR DEVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 50: REST OF WORLD NEUROVASCULAR DEVICES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 51: LEADING PLAYERS OPERATING IN REST OF WORLD NEUROVASCULAR DEVICES MARKET

TABLE 52: LIST OF MERGERS & ACQUISITIONS

TABLE 53: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 54: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 55: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: GLOBAL NEUROVASCULAR DEVICES MARKET, BY PRODUCT, IN 2020

FIGURE 6: GLOBAL NEUROVASCULAR DEVICES MARKET, BY EMBOLIZATION DEVICES, 2021-2028 (IN $ MILLION)

FIGURE 7: GLOBAL EMBOLIZATION DEVICES MARKET, BY EMBOLIC COILS, 2021-2028 (IN $ MILLION)

FIGURE 8: GLOBAL EMBOLIC COILS MARKET, BY COATED DETACHABLE COILS, 2021-2028 (IN $ MILLION)

FIGURE 9: GLOBAL EMBOLIC COILS MARKET, BY BARE DETACHABLE COILS, 2021-2028 (IN $ MILLION)

FIGURE 10: GLOBAL EMBOLIZATION DEVICES MARKET, BY COIL ASSIST STENT, 2021-2028 (IN $ MILLION)

FIGURE 11: GLOBAL EMBOLIZATION DEVICES MARKET, BY CLIPPINGS, 2021-2028 (IN $ MILLION)

FIGURE 12: GLOBAL EMBOLIZATION DEVICES MARKET, BY COIL ASSIST BALLOON, 2021-2028 (IN $ MILLION)

FIGURE 13: GLOBAL NEUROVASCULAR DEVICES MARKET, BY ACCESSORY DEVICES, 2021-2028 (IN $ MILLION)

FIGURE 14: GLOBAL ACCESSORY DEVICES MARKET, BY MICROCATHETERS, 2021-2028 (IN $ MILLION)

FIGURE 15: GLOBAL ACCESSORY DEVICES MARKET, BY MICRO GUIDEWIRES, 2021-2028 (IN $ MILLION)

FIGURE 16: GLOBAL NEUROVASCULAR DEVICES MARKET, BY REVASCULARIZATION DEVICES, 2021-2028 (IN $ MILLION)

FIGURE 17: GLOBAL REVASCULARIZATION DEVICES MARKET, BY CAROTID ARTERY STENTS, 2021-2028 (IN $ MILLION)

FIGURE 18: GLOBAL REVASCULARIZATION DEVICES MARKET, BY FLOW DIVERSION STENTS, 2021-2028 (IN $ MILLION)

FIGURE 19: GLOBAL NEUROVASCULAR DEVICES MARKET, BY THROMBECTOMY DEVICES, 2021-2028 (IN $ MILLION)

FIGURE 20: GLOBAL THROMBECTOMY DEVICES MARKET, BY CLOT RETRIEVAL DEVICES, 2021-2028 (IN $ MILLION)

FIGURE 21: GLOBAL THROMBECTOMY DEVICES MARKET, BY SUCTION AND ASPIRATION DEVICES, 2021-2028 (IN $ MILLION)

FIGURE 22: GLOBAL THROMBECTOMY DEVICES MARKET, BY SNARES, 2021-2028 (IN $ MILLION)

FIGURE 23: GLOBAL NEUROVASCULAR DEVICES MARKET, BY EMBOLIC PROTECTION DEVICES, 2021-2028 (IN $ MILLION)

FIGURE 24: GLOBAL EMBOLIC PROTECTION DEVICES MARKET, BY BALLOON OCCLUSION DEVICES, 2021-2028 (IN $ MILLION)

FIGURE 25: GLOBAL THROMBECTOMY DEVICES MARKET, BY DISTAL FILTER DEVICES, 2021-2028 (IN $ MILLION)

FIGURE 26: GLOBAL NEUROVASCULAR DEVICES MARKET, BY APPLICATION, IN 2020

FIGURE 27: GLOBAL NEUROVASCULAR DEVICES MARKET, BY ANEURYSM, 2021-2028 (IN $ MILLION)

FIGURE 28: GLOBAL NEUROVASCULAR DEVICES MARKET, BY ISCHEMIC STROKE, 2021-2028 (IN $ MILLION)

FIGURE 29: GLOBAL NEUROVASCULAR DEVICES MARKET, BY STENOSIS, 2021-2028 (IN $ MILLION)

FIGURE 30: GLOBAL NEUROVASCULAR DEVICES MARKET, BY ARTERIOVENOUS MALFORMATION (AVM), 2021-2028 (IN $ MILLION)

FIGURE 31: GLOBAL NEUROVASCULAR DEVICES MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 32: NORTH AMERICA NEUROVASCULAR DEVICES MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 33: UNITED STATES NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 34: CANADA NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 35: EUROPE NEUROVASCULAR DEVICES MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 36: GERMANY NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 37: UNITED KINGDOM NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 38: FRANCE NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 39: ITALY NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 40: RUSSIA NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 41: POLAND NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 42: BELGIUM NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 43: REST OF EUROPE NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 44: ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

FIGURE 45: CHINA NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 46: JAPAN NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 47: AUSTRALIA & NEW ZEALAND NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 48: INDIA NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 49: SOUTH KOREA NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 50: THAILAND NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 51: INDONESIA NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 52: VIETNAM NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 53: REST OF ASIA-PACIFIC NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 54: REST OF WORLD NEUROVASCULAR DEVICES MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 55: LATIN AMERICA NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

FIGURE 56: MIDDLE EAST & AFRICA NEUROVASCULAR DEVICES MARKET, 2021-2028 (IN $ MILLION)

  1. MARKET BY PRODUCT
    • EMBOLIZATION DEVICES
      • EMBOLIC COILS
        • COATED DETACHABLE COILS
        • BARE DETACHABLE COILS
      • COIL ASSIST STENT
      • CLIPPINGS
      • COIL ASSIST BALLOON
    • ACCESSORY DEVICES
      • MICROCATHETERS
      • MICRO GUIDEWIRES
    • REVASCULARIZATION DEVICES
      • CAROTID ARTERY STENTS
      • FLOW DIVERSION STENTS
    • THROMBECTOMY DEVICES
      • CLOT RETRIEVAL DEVICES
      • SUCTION AND ASPIRATION DEVICES
      • SNARES
    • EMBOLIC PROTECTION DEVICES
      • BALLOON OCCLUSION DEVICES
      • DISTAL FILTER DEVICES
  1. MARKET BY APPLICATION
    • ANEURYSM
    • ISCHEMIC STROKE
    • STENOSIS
    • ARTERIOVENOUS MALFORMATION (AVM)
    • OTHER APPLICATIONS
  2. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      •    COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    •  EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      •    COUNTRY ANALYSIS
        • GERMANY
        • UNITED KINGDOM
        • FRANCE
        • ITALY
        • RUSSIA
        • POLAND
        • BELGIUM
        • REST OF EUROPE
    •  ASIA-PACIFIC
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      •    COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • AUSTRALIA & NEW ZEALAND
        • INDIA
        • SOUTH KOREA
        • THAILAND
        • INDONESIA
        • VIETNAM
        • REST OF ASIA-PACIFIC
    •  REST OF WORLD
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      •    REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA

 

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    Choose License Type